Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
September 05 2024 - 4:00PM
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative
medical devices that improve spinal surgery outcomes, today
announced its participation in the upcoming Latin America Pain
Society (LAPS) Annual Congress September 5-7, 2024, in Mexico City.
The event will provide Aurora Spine with a platform to present
its latest advancements in minimally invasive spinal devices and
pain management solutions. These technologies are designed to
optimize patient care, reduce recovery times, and improve quality
of life. Aurora Spine’s cutting-edge developments focus on
addressing the unique challenges in spine and pain treatment,
positioning the company as a pioneer in the medical device
industry.
This world-class LAPS congress presents outstanding, nationally
and internationally renowned experts in pain management to share
their knowledge and present the opportunity to interact with
peers.
Matt Goldstone, Chief Commercial Officer of Aurora Spine,
stated, “We are very excited to be participating in this year’s
LAPS Conference. This world-class LAPS Congress showcases
cutting-edge advances and state-of-the-art technologies to present
the latest research, techniques and products for better patient
care.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal
implant and pain markets through a series of innovative, minimally
invasive, regenerative spinal implant technologies. Aurora Spine is
an emerging growth company focused on bringing new solutions to the
spinal implant and pain care markets through a series of screwless,
innovative, minimally invasive, regenerative spinal implant
technologies. Additional information can be accessed at
www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release
includes information concerning the proposed use and success of the
company’s products in surgical procedures. Aurora Spine cautions
investors of Aurora Spine's securities about important factors that
could cause Aurora Spine's actual results to differ materially from
those projected in any forward-looking statements included in this
news release. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward-looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent NorthcuttPresident and Chief Executive Officer(760)
424-2004
Chad ClouseChief Financial Officer(760)
424-2004www.aurora-spine.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Sep 2023 to Sep 2024